Tt Capital Management LLC Cassava Sciences Inc Transaction History
Tt Capital Management LLC
- $2.11 Trillion
- Q2 2025
A detailed history of Tt Capital Management LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Tt Capital Management LLC holds 15,500 shares of SAVA stock, worth $70,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,500Holding current value
$70,060% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
131Shares Held
14.2MCall Options Held
962KPut Options Held
864K-
Black Rock Inc. New York, NY3.22MShares$14.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$9.81 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny984KShares$4.45 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY790KShares$3.57 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY613KShares$2.77 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $181M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...